A lack of tolerance to the anxiolytic effects of diazepam on the plus-maze: comparison of male and female rats

被引:0
|
作者
H. Stock
C. Foradori
K. Ford
M. A. Wilson
机构
[1] University of South Carolina,
[2] School of Medicine,undefined
[3] Department of Pharmacology,undefined
[4] Columbia,undefined
[5] SC 29208,undefined
[6] USA e-mail: hstock@dcsmserver.med.sc.edu,undefined
来源
Psychopharmacology | 2000年 / 147卷
关键词
Key words Gender difference; Plus-maze; Benzodiazepine; Tolerance;
D O I
暂无
中图分类号
学科分类号
摘要
Rationale: The demonstration of tolerance to the anxiolytic effects of benzodiazepines remains inconsistent. Objectives: The present study tested the hypothesis that intact and gonadectomized male and female rats might exhibit differential tolerance to the anxiolytic effects of diazepam (DZ). Methods: Following acute (3 days) or chronic (3 weeks) DZ exposure, all animals were tested on the elevated plus-maze and immediately sacrificed for analysis of corticosterone, adrenocorticotropin hormone, estrogen and progesterone levels in serum. In experiment 2, following acute or chronic DZ exposure, animals were treated with a DZ challenge dose on the test day. Results: In experiment 1, both acute and chronic DZ treatment similarly enhanced percentage open arm time and entries, regardless of the hormonal status of the animal. The results of experiment 2 showed that both acute and chronic DZ-treated animals exhibited a significantly higher percentage open arm time than control animals after the DZ challenge dose, and males and females did not differ in their responses to DZ exposure. Conclusions: The findings from these experiments suggest that tolerance to the anxiolytic effects of DZ did not develop in males or females, and that the hormonal status of the animal does not significantly alter the anxiolytic effects of DZ following either acute or chronic exposure. Following plus-maze exposure, females had significantly higher corticosterone levels than males and acute DZ treatment diminished this stress response.
引用
收藏
页码:362 / 370
页数:8
相关论文
共 50 条
  • [1] A lack of tolerance to the anxiolytic effects of diazepam on the plus-maze: comparison of male and female rats
    Stock, H
    Foradori, C
    Ford, K
    Wilson, MA
    PSYCHOPHARMACOLOGY, 2000, 147 (04) : 362 - 370
  • [2] ONE-TRIAL TOLERANCE TO THE ANXIOLYTIC EFFECTS OF CHLORDIAZEPOXIDE IN THE PLUS-MAZE
    FILE, SE
    PSYCHOPHARMACOLOGY, 1990, 100 (02) : 281 - 282
  • [3] CHRONIC HANDLING MODIFIES THE ANXIOLYTIC EFFECT OF DIAZEPAM IN THE ELEVATED PLUS-MAZE
    BRETT, RR
    PRATT, JA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 178 (01) : 135 - 138
  • [4] Anxiolytic effects of ACE inhibitory peptides on the behavior of rats in an elevated plus-maze
    Yu, Zhipeng
    Zhao, Wenzhu
    Ding, Long
    Yu, Yiding
    Liu, Jingbo
    FOOD & FUNCTION, 2016, 7 (01) : 491 - 497
  • [5] Behavioral profiles displayed by rats in an elevated asymmetric plus-maze: effects of diazepam
    Ruarte, MB
    Alvarez, EO
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (01) : 99 - 106
  • [6] DEHYDROEPIANDROSTERONE IS AN ANXIOLYTIC IN MICE ON THE PLUS-MAZE
    MELCHIOR, CL
    RITZMANN, RF
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 47 (03) : 437 - 441
  • [7] L-arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats
    Volke, V
    Soosaar, A
    Koks, S
    Vasar, E
    Männistö, PT
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 351 (03) : 287 - 290
  • [8] Possible anxiolytic effects of taurine in the mouse elevated plus-maze
    Chen, SW
    Kong, WX
    Zhang, YJ
    Li, YL
    Mi, XJ
    Mu, XS
    LIFE SCIENCES, 2004, 75 (12) : 1503 - 1511
  • [9] DEVELOPMENT OF TOLERANCE TO ANXIOLYTIC EFFECTS OF CHLORDIAZEPOXIDE IN ELEVATED PLUS-MAZE TEST AND DECREASE OF GABA(A) RECEPTORS
    ISHIHARA, S
    HIRAMATSU, M
    KAMEYAMA, T
    NABESHIMA, T
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 91 (01) : 27 - 37
  • [10] EFFECTS OF DN-2327, A NEW ANXIOLYTIC, DIAZEPAM AND BUSPIRONE ON EXPLORATORY ACTIVITY OF THE RAT IN AN ELEVATED PLUS-MAZE
    WADA, T
    FUKUDA, N
    PSYCHOPHARMACOLOGY, 1991, 104 (04) : 444 - 450